The use of chitosan to enhance photodynamic inactivation against Candida albicans and its drug-resistant clinical isolates

International Journal of Molecular Sciences

Volumn 14, Issue 4, 2013, Pages 7445-7456

  Chien, Hsiung Fei ^a   Chen, Chueh Pin ^b   Chen, Yee Chun ^c   Chang, Po Han ^b   Tsai, Tsuimin ^d   Chen, Chin Tin ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Antimicrobial; Candida; Chitosan; Photodynamic inactivation

Indexed keywords

CHITOSAN; FLUCONAZOLE; PHOTOSENSITIZING AGENT; TOLONIUM CHLORIDE; COLORING AGENT;

ANTIFUNGAL RESISTANCE; ARTICLE; BINDING ASSAY; BIOFILM; CANDIDA ALBICANS; CELL DAMAGE; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; FUNGAL CELL; FUNGAL STRAIN; FUNGAL STRUCTURES; FUNGICIDAL ACTIVITY; FUNGUS ISOLATION; INCUBATION TIME; LIGHT EXPOSURE; MONOTHERAPY; NONHUMAN; PHOTODYNAMIC INACTIVATION; PHOTODYNAMIC THERAPY; PLANKTON; CANDIDIASIS; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; PHOTOCHEMOTHERAPY; PHYSIOLOGY;

CANDIDA; CANDIDA ALBICANS; EUKARYOTA;

BIOFILMS; CANDIDA ALBICANS; CANDIDIASIS; CHITOSAN; COLORING AGENTS; DRUG RESISTANCE, FUNGAL; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TOLONIUM CHLORIDE;

EID: 84875979378     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14047445     Document Type: Article

References (29)

1. Helander, I.M.; Nurmiaho-Lassila, E.L.; Ahvenainen, R.; Rhoades, J.; Roller, S. Chitosan disrupts the barrier properties of the outer membrane of gram-negative bacteria. Int. J. Food Microbiol. 2001, 71, 235-244.
2. Muzzarelli, R.; Tarsi, R.; Filippini, O.; Giovanetti, E.; Biagini, G.; Varaldo, P.E. Antimicrobial properties of N-carboxybutyl chitosan. Antimicrob. Agents Chemother. 1990, 34, 2019-2023.
3. Rabea, E.I.; Badawy, M.E.; Stevens, C.V.; Smagghe, G.; Steurbaut, W. Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules 2003, 4, 1457-1465.
4. Alonso, M.J.; Sanchez, A. The potential of chitosan in ocular drug delivery. J. Pharm. Pharmacol. 2010, 55, 1451-1463.
5. Ueno, H.; Yamada, H.; Tanaka, I.; Kaba, N.; Matsuura, M.; Okumura, M.; Kadosawa, T.; Fujinaga, T. Accelerating effects of chitosan for healing at early phase of experimental open wound in dogs. Biomaterials 1999, 20, 1407-1414.
6. Fontana, C.R.; dos Santos, D.S.J.; Bosco, J.M.; Spolidorio, D.M.; Marcantonio, R.A.C. Evaluation of chitosan gel as antibiotic and photosensitizer delivery. Drug Deliv. 2008, 15, 417-422.
7. Wang, X.H.; Li, D.P.; Wang, W.J.; Feng, Q.L.; Cui, F.Z.; Xu, Y.X.; Song, X.H.; van der Werf, M. Crosslinked collagen/chitosan matrix for artificial livers. Biomaterials 2003, 24, 3213-3220.
8. Hung, C.C.; Chen, Y.C.; Chang, S.C.; Luh, K.T.; Hsieh, W.C. Nosocomial candidemia in a university hospital in Taiwan. J. Formos. Med. Assoc. 1996, 95, 19-28.
9. Liu, C.Y.; Liao, C.H.; Chen, Y.C.; Chang, S.C. Changing epidemiology of nosocomial bloodstream infections in 11 teaching hospitals in Taiwan between 1993 and 2006. J. Microbiol. Immunol. Infect. 2010, 43, 416-429.
10. Phelan, J.A.; Saltzman, B.R.; Friedland, G.H.; Klein, R.S. Oral findings in patients with acquired immunodeficiency syndrome. Oral Surg. Oral Med. Oral Pathol. 1987, 64, 50-56.
11. Ballard, J.; Edelman, L.; Saffle, J.; Sheridan, R.; Kagan, R.; Bracco, D.; Cancio, L.; Cairns, B.; Baker, R.; Fillari, P.; et al. Positive fungal cultures in burn patients: A multicenter review. J. Burn Care Res. 2008, 29, 213-221.
12. Ballal, N.V.; Kundabala, M.; Bhat, K.S.; Acharya, S.; Ballal, M.; Kumar, R.; Prakash, P.Y. Susceptibility of Candida albicans and Enterococcus faecalis to Chitosan, Chlorhexidine gluconate and their combination in vitro. Aust. Endod. J. 2009, 35, 29-33.
13. Hamblin, M.R.; Hasan, T. Photodynamic therapy: A new antimicrobial approach to infectious disease? Photochem. Photobiol. Sci. 2004, 3, 436-450.
14. Jori, G.; Fabris, C.; Soncin, M.; Ferro, S.; Coppellotti, O.; Dei, D.; Fantetti, L.; Chiti, G.; Roncucci, G. Photodynamic therapy in the treatment of microbial infections: Basic principles and perspective applications. Lasers Surg. Med. 2006, 38, 468-481.
15. Winckler, K.D. Special section: Focus on anti-microbial photodynamic therapy (PDT). J. Photochem. Photobiol. B 2007, 86, 43-44.
16. Wainwright, M.; Crossley, K.B. Photosensitising agents-Circumventing resistance and breaking down biofilms: A review. Int. Biodeter Biodeg. 2004, 53, 119-126.
17. Francesco, G.; Manuele, M.; Annalisa, C.; Debora, A.; Lia, F.; Gabrio, R. In vitro resistance selection studies of RLP068/Cl, a new Zn(II) phthalocyanine suitable for antimicrobial photodynamic therapy. Antimicrob. Agents Chemother. 2010, 54, 637-642.
18. Zeina, B.; Greenman, J.; Purcell, W.M.; Das, B. Killing of cutaneous microbial species by photodynamic therapy. Br. J. Dermatol. 2001, 144, 274-278.
19. Souza, R.C.; Junqueira, J.C.; Rossoni, R.D.; Pereira, C.A.; Munin, E.; Jorge, A.O. Comparison of the photodynamic fungicidal efficacy of methylene blue, toluidine blue, malachite green and low-power laser irradiation alone against Candida albicans. Lasers Med. Sci. 2010, 25, 385-389.
20. Zeina, B.; Greenman, J.; Corry, D.; Purcell, W.M. Cytotoxic effects of antimicrobial photodynamic therapy on keratinocytes in vitro. Br. J. Dermatol. 2002, 146, 568-573.
21. Soukos, N.S.; Wilson, M.; Burns, T.; Speight, P.M. Photodynamic effects of toluidine blue on human oral keratinocytes and fibroblasts and Streptococcus sanguis evaluated in vitro. Lasers Surg. Med. 1996, 18, 253-259.
22. Zeina, B.; Greenman, J.; Corry, D.; Purcell, W.M. Antimicrobial photodynamic therapy: Assessment of genotoxic effects on keratinocytes in vitro. Br. J. Dermatol. 2003, 148, 229-232.
23. Tsai, T.; Chien, H.F.; Wang, T.H.; Huang, C.T.; Ker, Y.B.; Chen, C.T. Chitosan augments photodynamic inactivation of gram-positive and gram-negative bacteria. Antimicrob. Agents Chemother. 2011, 55, 1883-1890.
24. Tsai, T.; Yang, Y.T.; Wang, T.H.; Chien, H.F.; Chen, C.T. Improved photodynamic inactivation of gram-positive bacteria using hematoporphyrin encapsulated in liposomes and micelles. Lasers Surg. Med. 2009, 41, 316-322.
25. Nett, J.E.; Guite, K.M.; Ringeisen, A.; Holoyda, K.A.; Andes, D.R. Reduced biocide susceptibility in Candida albicans biofilms. Antimicrob. Agents Chemother. 2008, 52, 3411-3413.
26. Chandra, J.; Kuhn, D.M.; Mukherjee, P.K.; Hoyer, L.L.; McCormick, T.; Ghannoum, M.A. Biofilm formation by the fungal pathogen Candida albicans: Development, architecture, and drug resistance. J. Bacteriol. 2001, 183, 5385-5394.
27. Ganan, M.; Carrascosa, A.V.; Martinez-Rodriguez, A.J. Antimicrobial activity of chitosan against Campylobacter spp. and other microorganisms and its mechanism of action. J. Food Prot. 2009, 72, 1735-1738.
28. Park, Y.; Kim, M.H.; Park, S.C.; Cheong, H.; Jang, M.K.; Nah, J.W.; Hahm, K.S. Investigation of the antifungal activity and mechanism of action of LMWS-Chitosan. J. Microbiol. Biotechnol. 2008, 18, 1729-1734.
29. Jin, Y.; Yip, H.K.; Samaranayake, Y.H.; Yau, J.Y.; Samaranayake, L.P. Biofilm-forming a ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection. J. Clin. Microbiol. 2003, 41, 2961-2967.